LONDON (Thomson Financial) - Investors tucked into Proteome Science Plc.,
storming 10 pence higher to 47-1/2, as it announced late yesterday it has
entered into an exclusive license agreement for its TMT isobaric tandem mass tag
technology with Thermo Fisher Scientific Inc.
David.Brett@thomson.com
dkb/slj
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|